首页 > 市场调查报告书 > 医疗设备

体外诊断

医疗分析检测服务市场规模、份额和成长分析（按类型、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1899194

医疗分析检测服务市场规模、份额和成长分析（按类型、最终用户和地区划分）－2026-2033年产业预测

Healthcare Analytical Testing Services Market Size, Share, and Growth Analysis, By Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 168 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，医疗分析测试服务市场规模将达到 82.2 亿美元，到 2025 年将达到 91.4 亿美元，到 2033 年将达到 213.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.2%。

医疗分析检测服务市场的成长主要受临床试验数量增加、生物相似药发展以及製药公司外包业务成长的推动。新冠疫情加速了市场扩张，推动了对分析检测服务的需求，以支持治疗方法和疫苗的快速研发。儘管疫情初期造成的衝击影响了市场成长，但随后疫苗接种活动的激增和医疗设备创新已使该行业重焕生机。此外，竞争压力和快速进入市场的需求也促使企业将检测服务外包。生物相似药和组合产品的兴起，以及新参与企业市场的企业日益严格的监管合规要求，进一步凸显了对特定分析检测解决方案的迫切需求。

医疗分析检测服务市场驱动因素

对医疗检测服务需求的不断增长正显着推动医疗分析检测服务市场的发展。这一增长主要源于人口老化和慢性病盛行率的显着上升，从而带动了对诊断检测及相关分析服务的需求。个人化医疗的趋势也发挥关键作用，而个人化医疗高度依赖先进的检测和分析能力。此外，医疗专业人员和生物製药公司对分析检测投入的不断增加也推动了市场的发展。随着对准确可靠诊断结果的需求日益增长，医疗检测服务的扩张预计将持续下去。

医疗分析测试服务市场的限制因素

医疗分析检测服务市场面临许多挑战，主要原因在于其高成本和固有的复杂性。提供这些分析检测服务需要先进的软体、专用设备和训练有素的人员，这些因素都推高了价格。此外，检测和分析本身的复杂性也可能导致误差和不一致，从而阻碍市场发展。这些障碍对中小企业的影响尤其显着，使它们难以投入资源进行分析检测服务。因此，相关的成本和复杂性可能会抑制整体市场成长，因为企业在权衡利弊时会做出艰难的抉择。

医疗分析检测服务市场的发展趋势

医疗保健分析检测服务市场正呈现出明显的趋势，即分析检测服务外包，尤其是在生物技术和製药公司中。这项转变的主要驱动力是降低营运成本、利用先进技术以及专注于核心竞争力。透过将分析检测外包给专业服务供应商，企业可以提高生产效率并缩短交付时间，从而依靠拥有必要专业知识和资源的供应商。随着对分析检测服务需求的持续增长，外包将成为越来越受欢迎的策略，使企业能够优化营运并在医疗保健领域保持竞争力。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Eurofins Scientific（Luxembourg）
Laboratory Corporation of America Holdings（US）
SGS SA（Switzerland）
Charles River Laboratories（US）
WuXi AppTec Co. Ltd.（China）
Element Materials Technology（UK）
Thermo Fisher Scientific, Inc.（US）
Pace Analytical Services LLC（US）
Intertek Group plc（UK）
IQVIA Inc.（US）
Merck KGaA（Germany）
Source BioScience（UK）
Almac Group（UK）
ICON Plc（Ireland）
Frontage Laboratories, Inc.（US）
STERIS Plc（US）
Sartorius AG（Germany）
ALS Life Science（US）
Syneos Health, INC（US）
Medpace Holdings, Inc.（US）

简介目录

Product Code: SQMIG35D2273

Healthcare Analytical Testing Services Market size was valued at USD 8.22 Billion in 2024 and is poised to grow from USD 9.14 Billion in 2025 to USD 21.36 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026-2033).

The growth of the Healthcare Analytical Testing Services market is primarily driven by the rising number of clinical trials, an emphasis on biosimilars, and increased outsourcing by pharmaceutical companies. The COVID-19 pandemic has acted as a catalyst for market expansion, spurring demand for analytical testing services in response to the rapid development of treatments and vaccines. While initial disruptions from the pandemic impacted growth, the subsequent surge in vaccination efforts and innovation in medical equipment revitalized the sector. Additionally, competitive pressures and the demand for expedited market entry have prompted companies to outsource testing services. The rise of biosimilars, combination products, and regulatory compliance requirements by firms entering new markets further underscores the critical need for specific analytical testing solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Healthcare Analytical Testing Services Market Segments Analysis

Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Healthcare Analytical Testing Services Market

The rising demand for medical testing services significantly propels the growth of the Healthcare Analytical Testing Services market. This surge is largely attributed to an aging population and a notable increase in chronic health conditions, which in turn elevates the need for diagnostic testing and related analytical services. The trend towards personalized medicine also plays a critical role, as it relies heavily on sophisticated testing and analytical capabilities. Furthermore, increased investments from healthcare professionals and biopharmaceutical companies in analytical testing are driving momentum within the market. As the need for accurate and reliable diagnostic results becomes ever more vital, the expansion of healthcare testing services is expected to persist.

Restraints in the Healthcare Analytical Testing Services Market

The Healthcare Analytical Testing Services market faces significant challenges primarily due to high costs and the inherent complexity of services. The provision of these analytical testing services necessitates sophisticated software, specialized equipment, and highly trained personnel, which contribute to elevated pricing. Additionally, the intricate nature of both testing and analysis can result in errors and inconsistencies, potentially hindering market development. These barriers particularly affect small and medium-sized enterprises, making it difficult for them to commit resources to analytical testing services. Consequently, the associated costs and complexities may restrain overall market growth as businesses evaluate the advantages relative to the drawbacks.

Market Trends of the Healthcare Analytical Testing Services Market

The healthcare analytical testing services market is experiencing a significant trend towards the outsourcing of analytical testing services, particularly among biotechnology and pharmaceutical companies. This shift is largely driven by the desire to reduce operational costs, leverage advanced technologies, and concentrate on core business functions. By outsourcing analytical testing to specialized service providers, organizations are enhancing their productivity and achieving quicker turnaround times, as these vendors offer the necessary expertise and resources. As the demand for analytical testing services continues to expand, outsourcing is set to become an increasingly popular strategy, enabling companies to optimize their operations and maintain competitiveness in the healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Startup Analysis
Technology Analysis
Innovation Matrix
Market Attractiveness Index, 2025

Healthcare Analytical Testing Services Market, By Type

Market Overview
Medical Device Analytical Testing Services
- Extractable and Leachable
- Material Characterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
Pharmaceutical Analytical Testing Services
- Bioanalytical Testing
- Method Development & Validation
- Stability Testing
- Other Testing Services

Healthcare Analytical Testing Services Market, By End User

Market Overview
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Hospitals & Clinics
Forensic Labs
Cosmetic & Nutraceutical Companies

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS S.A. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Element Materials Technology (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pace Analytical Services LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Source BioScience (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERIS Plc (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALS Life Science (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, INC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments